Pilot tolerability and effectiveness study of levetiracetam for postherpetic neuralgia.
D018712:Analgesics, Non-Narcotic / Q000009:adverse effects / Q000627:therapeutic use*; D002121:Calcium Channel Blockers / Q000009:adverse effects / Q000627:therapeutic use; D005221:Fatigue / Q000139:chemically induced; D005260:Female; D006562:Herpes Zoster / Q000150:complications; D006801:Humans; D000077287:Levetiracetam; D008297:Male; D009437:Neuralgia / Q000188:drug therapy* / Q000209:etiology; D010865:Pilot Projects; D010889:Piracetam / Q000009:adverse effects / Q000031:analogs & derivatives / Q000494:pharmacology / Q000627:therapeutic use*; D011446:Prospective Studies; D018079:Receptors, GABA / Q000187:drug effects; D018009:Receptors, Glycine / Q000187:drug effects; D016896:Treatment Outcome
D018712:Analgesics, Non-Narcotic; D002121:Calcium Channel Blockers; D018079:Receptors, GABA; D018009:Receptors, Glycine; D000077287:Levetiracetam; D010889:Piracetam